Beta-blockers after STEMI: prognostic impact and predictors of adherence, results from the real-world FAST-STEMI registry

Back

ESC Professional Premium Access

Beta-blockers after STEMI: prognostic impact and predictors of adherence, results from the real-world FAST-STEMI registry

Session: Pharmacotherapy of acute coronary syndromes in clinical practice

Topic: Pharmacotherapy

Speaker: Doctor E. Ravetti (Turin, IT)

Event: ESC Congress 2023

Congress Presentation

Add to my library

About the speaker

Doctor Emanuele Ravetti

Hospital Citta Della Salute e della Scienza di Torino, Turin (Italy)

2 presentations

0 follower

6 more presentations in this session

Changes of hospital-level variation in use of optimal medical treatment for long-term follow-up from a multi-level methodological approach

Speaker: Doctor H. Kwak (Daegu, KR)

Access

Abstract

Slides

Almost 1 in 2 patients with acute coronary syndrome are extremely high-risk and potential candidates for in-hospital triple lipid-lowering therapy: data from the CALLINICUS-Hellas Registry

Speaker: Professor L. Rallidis (Athens, GR)

Clinical impact of high platelet reactivity in patients with atrial fibrillation and concomitant percutaneous coronary intervention on dual or triple antithrombotic therapy

Speaker: Professor R. Marcucci (Florence, IT)

One-month dual antiplatelet therapy following stent implantation in patients with acute coronary syndromes and high bleeding risk

Speaker: Doctor C. Pivato (Milan, IT)

Ticagrelor versus Clopidogrel in diabetes patients afflicted with acute coronary syndrome stratified by renal function

Speaker: Doctor T. Wang (Taipei, TW)

Access the full session

Pharmacotherapy of acute coronary syndromes in clinical practice

Speakers: Doctor E. Ravetti, Doctor H. Kwak, Professor L. Rallidis, Professor R. Marcucci, Doctor C. Pivato...

Access

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources